·5 min read

A reader sent us a peptide vial. Here's what I got wrong reading just the photo.

A friend just starting peptides got a three-in-one vial in the mail. The label looked sketchy at first glance. Then the actual data showed something different. The lesson is what changes when you stop trusting the photo.

A reader sent me a photo this week. His friend just started peptides and got a vial in the mail. The label said:

Three peptides in one vial. Clean modern packaging, green accent label, "S" logo. He wanted my read on whether it was real.

This post is the answer, plus the part I got wrong on the first look.

What the photo alone told me

Honestly, my first read was skeptical. Here's the list of things that looked like flags from the image alone:

Three peptides in one vial is unusual. Real pharmaceutical companies never combine three different peptides this way. Licensed compounding pharmacies almost never do either. The reason is practical: once you mix the powder with water (the reconstitution step), you're locked into whatever ratio the vendor put in. If a doctor wanted you on all three, they'd write three separate vials so you could dose each one independently.

"Research use only" is a legal hedge. It's the disclaimer gray-market peptide sellers use so they don't have to be regulated as a drug company. The buyer gets the vial and uses it on themselves anyway. Standard pattern in 2026.

"99% purity" is a number on a sticker until you see the lab work. The claim is universal across this market. The verification is what separates the real operators from the marketing-only ones.

The label was missing things I'd want to see. No batch number visible in the photo. No expiration date. No manufacturer (Skye is the seller, but who actually compounded the powder?). No country of origin.

Based on the photo alone I would have scored Skye Peptides somewhere around 40 out of 100 on our 11-signal rubric. Tier 3 research-chem with weak documentation.

What the actual data showed

Then I looked them up properly and the picture changed.

Skye Peptides has an A rating from Finnrick Analytics, which is the closest thing to an independent peptide testing service this market has. Finnrick is one of our biggest indirect competitors on the trust axis, and they don't hand out A ratings casually.

The Skye COAs name their analytical labs by name: TrustPointe Analytics and MZ Biolabs. That's a meaningful detail. Most research-chem operators show you a "COA" that doesn't actually trace back to a real lab. The named-lab pattern is the signal that separates Tier 2 (licensed compounded with documentation) from Tier 3 (research-chem with weak documentation).

Their published test reports are dated 2024 and 2025, suggesting an ongoing batch-testing practice rather than a one-time setup.

Trustpilot reviews are positive. Finnrick test requests submitted by community members average 5.0 out of 5 across 7 reports.

After the actual data, I'd score them around 62 out of 100. Conditional verdict (research-chem framing means they don't get the routable badge that requires a clinical workflow), but the documentation rigor is meaningfully better than I'd assumed from the photo alone.

That's a 22-point swing. The photo and the data were telling different stories.

What this means for your friend

The vial isn't fake or dangerous. The brand has documentation infrastructure. The "99% purity" is at least sometimes backed by verifiable third-party COAs.

The questions worth asking the vendor before he uses it:

What's the lot number on this specific vial, and can I see the COA for that batch? A real answer matches the lot to a specific PDF dated within the last six months. A vague answer or no answer means they have testing infrastructure but not for the specific batch he received.

What's the expected ratio of the three peptides at the doses I want? Because they're pre-mixed in one vial, dosing GHK-Cu separately from TB-500 separately from BPC-157 isn't possible. He's locked into whatever the vendor decided. If his target dose for one of the three doesn't match what the vial provides at the volumes he'd inject, the format isn't right for him.

How long does it stay good after reconstitution? Different peptides have different stability windows once mixed with bacteriostatic water. The shortest of the three becomes the limit for the whole vial.

If he gets clean answers to those three, the product is reasonable to use at his own risk. If he doesn't, the product is reasonable to skip.

The bigger lesson

The photo was telling me one story. The actual data was telling me another. The difference matters.

This is also the reason vendor-quality assessment is hard. You can't read a label and know what's real. You need:

  • The vendor's published testing infrastructure
  • The lot-specific COA for the batch you received
  • A third-party reference (Finnrick is the gold standard here)
  • The brand's track record across multiple batches

Panya tries to do this work for vendors at scale (we score 77 of them on the 11-signal rubric), but for any individual vial, the verification still falls on the buyer.

If you got a vial in the mail and you're not sure what to make of it, send a photo. We added Skye Peptides to the vendor catalog this week because of this reader's email. Next reader's vial might be the next entry.

Email: editor@panya.health. Photo of the label is enough.

Share this post
Friday digest

One email a week. Catalog updates, new posts, BKK supply state. No spam, no MLM. What lands in the inbox →

We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.

About the editor

Mira Tanaka is the editor at panya, based in Bangkok. Editor at Panya. Covers peptide therapeutics with a focus on the routing decisions mainstream adults actually face. Corrections, tips, or push-back: editor@panya.health.